BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7711510)

  • 1. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
    Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
    Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
    Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
    Akamizu T; Inoue D; Kosugi S; Kohn LD; Mori T
    Thyroid; 1994; 4(1):43-8. PubMed ID: 8054860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on homologous desensitization of the thyrotropin receptor in 293 human embryonal kidney cells.
    Nagayama Y; Chazenbalk GD; Takeshita A; Kimura H; Ashizawa K; Yokoyama N; Rapoport B; Nagataki S
    Endocrinology; 1994 Sep; 135(3):1060-5. PubMed ID: 8070347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction.
    Akamizu T; Inoue D; Kosugi S; Ban T; Kohn LD; Imura H; Mori T
    Endocr J; 1993 Jun; 40(3):363-72. PubMed ID: 7920890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin binding specificity for the thyrotropin receptor.
    Nagayama Y; Yamasaki H; Takeshita A; Kimura H; Ashizawa K; Yokoyama N; Yamashita S; Rapoport B; Nagataki S
    J Endocrinol Invest; 1995 Apr; 18(4):283-7. PubMed ID: 7560810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells.
    Shi Y; Zou M; Parhar RS; Farid NR
    Thyroid; 1993; 3(2):129-33. PubMed ID: 8396480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.
    Nagayama Y; Wadsworth HL; Chazenbalk GD; Russo D; Seto P; Rapoport B
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):902-5. PubMed ID: 1992482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
    Tahara K; Ban T; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins.
    Seetharamaiah GS; Zhuang J; Huang J; Patibandla SA; Kaithamana S; Tahara K; Kohn LD; Prabhakar BS
    Thyroid; 1999 Sep; 9(9):879-86. PubMed ID: 10524566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding.
    Nagayama Y; Russo D; Wadsworth HL; Chazenbalk GD; Rapoport B
    J Biol Chem; 1991 Aug; 266(23):14926-30. PubMed ID: 1651314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.
    Nagayama Y; Wadsworth HL; Russo D; Chazenbalk GD; Rapoport B
    J Clin Invest; 1991 Jul; 88(1):336-40. PubMed ID: 1711544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.